MML Investors Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.2M | Buy |
70,299
+6,873
| +11% | +$2.55M | 0.06% | 326 |
|
|
2026
Q1 | $18.6M | Sell |
63,426
-9,891
| -13% | -$3.25M | 0.05% | 352 |
|
|
2025
Q4 | $25.7M | Sell |
73,317
-3,083
| -4% | -$1.04M | 0.06% | 295 |
|
|
2025
Q3 | $24.7M | Sell |
76,400
-3,551
| -4% | -$1.1M | 0.07% | 284 |
|
|
2025
Q2 | $31.1M | Sell |
79,951
-3,048
| -4% | -$1.23M | 0.09% | 218 |
|
|
2025
Q1 | $36.1M | Buy |
82,999
+8,643
| +12% | +$3.47M | 0.12% | 179 |
|
|
2024
Q4 | $27.4M | Buy |
74,356
+10,527
| +16% | +$4.41M | 0.09% | 215 |
|
|
2024
Q3 | $33.2M | Buy |
63,829
+2,172
| +4% | +$1.16M | 0.12% | 180 |
|
|
2024
Q2 | $33.4M | Sell |
61,657
-8,365
| -12% | -$4.42M | 0.14% | 166 |
|
|
2024
Q1 | $36.3M | Buy |
70,022
+3,039
| +5% | +$1.51M | 0.15% | 154 |
|
|
2023
Q4 | $31.6M | Buy |
66,983
+12,828
| +24% | +$5.93M | 0.15% | 161 |
|
|
2023
Q3 | $23.6M | Buy |
54,155
+7,063
| +15% | +$3.2M | 0.13% | 175 |
|
|
2023
Q2 | $20.9M | Buy |
+47,092
| New | +$21.7M | 0.12% | 196 |
|
|
2023
Q1 | – | Sell |
-42,295
| Closed | -$21.7M | – | 2133 |
|
|
2022
Q4 | $21.7M | Buy |
42,295
+4,823
| +13% | +$2.45M | 0.14% | 160 |
|
|
2022
Q3 | $17M | Sell |
37,472
-1,114
| -3% | -$533K | 0.13% | 177 |
|
|
2022
Q2 | $18.6M | Buy |
38,586
+2,780
| +8% | +$1.38M | 0.14% | 166 |
|
|
2022
Q1 | $17.6M | Buy |
35,806
+4,182
| +13% | +$1.91M | 0.12% | 187 |
|
|
2021
Q4 | $14.7M | Buy |
31,624
+2,233
| +8% | +$939K | 0.11% | 208 |
|
|
2021
Q3 | $11M | Buy |
29,391
+3,521
| +14% | +$1.34M | 0.09% | 254 |
|
|
2021
Q2 | $9.88M | Buy |
25,870
+2,246
| +10% | +$858K | 0.08% | 257 |
|
|
2021
Q1 | $8.48M | Buy |
23,624
+1,587
| +7% | +$510K | 0.08% | 252 |
|
|
2020
Q4 | $7.08M | Buy |
22,037
+791
| +4% | +$243K | 0.08% | 255 |
|
|
2020
Q3 | $5.71M | Buy |
21,246
+1,360
| +7% | +$366K | 0.07% | 254 |
|
|
2020
Q2 | $5.23M | Buy |
19,886
+343
| +2% | +$91.5K | 0.07% | 256 |
|
|
2020
Q1 | $4.44M | Buy |
19,543
+1,166
| +6% | +$318K | 0.08% | 242 |
|
|
2019
Q4 | $5.55M | Sell |
18,377
-954
| -5% | -$263K | 0.08% | 244 |
|
|
2019
Q3 | $4.64M | Sell |
19,331
-1,929
| -9% | -$529K | 0.07% | 251 |
|
|
2019
Q2 | $6M | Buy |
21,260
+4,947
| +30% | +$1.35M | 0.09% | 234 |
|
|
2019
Q1 | $4.68M | Buy |
16,313
+4,231
| +35% | +$1.22M | 0.07% | 260 |
|
|
2018
Q4 | $3.17M | Buy |
12,082
+297
| +3% | +$81.7K | 0.06% | 311 |
|
|
2018
Q3 | $3.23M | Buy |
11,785
+2,990
| +34% | +$776K | 0.05% | 310 |
|
|
2018
Q2 | $2.09M | Buy |
8,795
+1,233
| +16% | +$286K | 0.05% | 339 |
|
|
2018
Q1 | $1.66M | Buy |
7,562
+2,250
| +42% | +$529K | 0.04% | 394 |
|
|
2017
Q4 | $1.2M | Buy |
5,312
+1,992
| +60% | +$424K | 0.02% | 483 |
|
|
2017
Q3 | $630K | Buy |
3,320
+363
| +12% | +$69.1K | 0.01% | 685 |
|
|
2017
Q2 | $556K | Buy |
2,957
+220
| +8% | +$39.5K | 0.01% | 725 |
|
|
2017
Q1 | $453K | Buy |
+2,737
| New | +$435K | 0.01% | 470 |
|
Other funds holding ELV
AACR
MML Investors Services's ELV Position: Q2 2026 in Review
MML Investors Services increased its Elevance Health (ELV) stake by 11% in Q2 2026, buying an estimated $2.55M and bringing the position to 70,299 shares worth $27.2M. The position accounts for 0.06% of the portfolio, ranked #326.
MML Investors Services first reported a position in ELV in Q1 2017 and has held it in 37 quarters since. The position peaked at $36.3M in Q1 2024. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- MML Investors Services held 70,299 shares of Elevance Health worth $27.2M as of Q2 2026.
- MML Investors Services bought 6,873 Elevance Health shares in Q2 2026, an estimated $2.55M.
- Elevance Health made up 0.06% of MML Investors Services's portfolio in Q2 2026, its #326 holding.
- MML Investors Services first reported a position in Elevance Health in Q1 2017 and has held it in 37 quarters since.
- MML Investors Services's Elevance Health position peaked at $36.3M in Q1 2024.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.